Page 46 - Gates-AnnualReport-2017

NEW FACES
AT THE GATES CENTER
Ryan Crisman, Ph.D: Effective August 2017, Ryan Crisman joined the Gates Center as the Gates Biomanufacturing Facility’s new Director of Cell Processing and now serves as interim Facility Director. Prior to arriving on the Anschutz Medical Campus, Ryan was associate director—head of late stage process development and CMC lead of JCAR017 for Juno Therapeutics in Seattle, WA, which licensed in CAR-T cell technology developed by Terry J. Fry, M.D., one of the leading cancer researchers in the country and a new recruit to the Anschutz Medical Center.
Ryan grew up in the State of Washington in a small logging town outside Seattle and went on to receive his Ph.D. in Chemical and Biological Engineering at the University of Colorado Boulder. While there, he and Gates Biomanufacturing Center’s Director of Protein Chemistry & Manufacturing Matt Seefeldt worked together under advisor Dr. Theodore Randolph, considered “a world leader in protein stabilization and supercritical fluid technology in processes for
enzymatic catalysis, particle formation, and drug delivery.”
A recipient of numerous honors and awards, Ryan likes the idea of being affiliated with a superb facility within an academic institution with great science and for-profit industry opportunities. He looks forward to getting back to his roots in cutting-edge research as well as staying close to the CAR-T area and working with Terry Fry to pave the way for other cell therapies to serve as-yet-unmet patient needs. In the meantime, we feel fortunate to have added Ryan’s skills in GMP process manufacturing, FDA regulations and team building to those of our accomplished and growing Gates Biomanufacturing staff. It’s great to have Ryan, his wife and labradoodle now with us in Colorado!
Christopher Garbe, M.S., M.B.A: Christopher Garbe joined the Gates Center as the Gates Biomanufacturing Facility’s Director of Quality in the final days of 2017. Formerly the director of quality control/analytical development of cellular therapeutics and interim director of process development at the Fred Hutchinson Cancer Research Center in Seattle, WA, Christopher heard about the position from our Interim Facility Director Ryan Crisman, with whom he worked at Zymogenetics, Inc; a Bristol-Myers Squibb Company, also in Seattle.
Chris describes himself as a military brat, whose father was “tethered” to the Navy for 30 years. As such, he was born in Rota, Spain, and spent his formative years living up and down the East Coast from Florida to
Rhode Island, as well as in Stuttgart, Germany, where he attended high school.
46 Gates Center for Regenerative Medicine